GPAT

GATE 2025 will be conducted for 30 subjects and it would be distributed over Saturday 1st Sunday 2nd, Saturday 15th and Sunday 16th of February 2025. GATE 2025 examination will be conducted in several cities across India. GATE 2025 will not be conducted in centres outside India.

M.Pharm. in Pharmaceutical Chemistry, Pharmaceutical Analysis with minimum 55% marks from a recognized institution or a recognized qualification equivalent thereto. Ph.D. Degree in Pharmaceutical Chemistry, Pharmaceutical Analysis from a recognized institution, university.

Candidate must have a First class in M.Pharm, M.S.Pharm, M.Tech. Pharm, M.Tech. in Pharmaceutics, Pharmacology, Biotechnology with GATE, GPAT, CSIR-NET or equivalent examination. The candidates should have a 1st calls in degree in pharmacy

Ph.D awarded or submitted organic, medicinal chemistry. Should have experience in synthesis of chiral molecules, multi-step synthesis, synthesis of API, Total synthesis of natural products.

M.Pharm in Pharmaceutical Sciences with First class. NET, GATE, GPAT qualified candidates with research experience and publications in peer- reviewed journals will be preferred.

M.Pharm in Pharmaceutics, Pharmacology, Pharmaceutical Biotechnology and preferably GPAT qualified.

The candidate must have a M.S, M.Pharm, degree in Medicinal chemistry, Natural Products, Pharmaceutical Analysis from a PCI, AICTE, UGC, NAAC recognized, accredited University, Central Autonomous Institutes with 60% marks or above.

Master Degree in Pharmaceutical Sciences First-class with GPAT qualification Preferably in Pharmaceutics from a recognized University. developing nanoformulations, mammalian cell cultures, and in vivo experiments. Synthesis of Polymers, peptides Characterization of physicochemical Parameter, Determination of anticancer therapeutic effect in the in vitro assay systems, Validation of the in vitro results in the in vivo animal models of tumor-bearing mice model and infectious disease models

Antiviral Mission: CSIR Discovery and Pre-clinical Development of Antivirals for COVID-19 and other diseases. reclinical Pharmaceutics and pharmacokinetic studies of CDRI candidate drugs, formulations and phytopharmaceuticals. M.Pharm. with GPAT qualified. Master in Chemistry, Chemical Sciences, Pharmaceutical Chemistry.